NCT07558499

Brief Summary

This study aims to evaluate the effect of rectal administration of maternal breast milk on gut microbiota development in preterm infants. Preterm infants are at increased risk of dysbiosis due to immaturity and limited enteral feeding in the early postnatal period. In this randomized controlled study, preterm infants will receive either rectal administration of maternal breast milk or normal saline. The primary objective is to compare gut microbiota composition between the two groups. The findings may provide insight into a novel and non-invasive strategy to support microbiota development in preterm infants.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
14mo left

Started Jun 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 30, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

June 15, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2027

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2027

Last Updated

April 30, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

March 17, 2026

Last Update Submit

April 22, 2026

Conditions

Keywords

prematuregut microbiotapreterm morbidities

Outcome Measures

Primary Outcomes (1)

  • Gut microbiota composition in preterm infants

    Gut microbiota composition will be analyzed using stool samples collected from preterm infants at 7 days and 1 month of life, including assessment of microbial diversity and relative abundance of bacterial taxa, to evaluate differences between study groups.

    1 year

Secondary Outcomes (3)

  • Time to full enteral feeding

    1 year

  • Feeding intolerance

    1 year

  • Necrotizing enterocolitis

    1 year

Study Arms (2)

Rectal irrigation with maternal breast milk

EXPERIMENTAL

Rectal irrigation will be performed starting 48 hours after birth, twice daily for 5 consecutive days at 09:00 and 21:00. A 6 Fr feeding tube, 5 mL syringe, thermostatically controlled water bath (set at 37°C), sterile water-based lubricant, and sterile gloves will be used. The enema volume will be calculated as 5 mL/kg and warmed to 37°C. One end of the feeding tube will be connected to the syringe, and the other end will be gently inserted into the rectum after lubrication. The solution will be administered slowly over approximately 3 minutes, and the tube will then be carefully removed. Maternal breast milk will be used for rectal irrigation.

Other: Rectal irrigation with maternal breast milk

Rectal irrigation with normal saline

ACTIVE COMPARATOR

Rectal irrigation will be performed starting 48 hours after birth, twice daily for 5 consecutive days at 09:00 and 21:00. A 6 Fr feeding tube, 5 mL syringe, thermostatically controlled water bath (set at 37°C), sterile water-based lubricant, and sterile gloves will be used. The enema volume will be calculated as 5 mL/kg and warmed to 37°C. One end of the feeding tube will be connected to the syringe, and the other end will be gently inserted into the rectum after lubrication. The solution will be administered slowly over approximately 3 minutes, and the tube will then be carefully removed.Normal saline will be used for rectal irrigation as an active comparator.

Other: Rectal irrigation with salin

Interventions

Maternal breast milk will be used for rectal irrigation . Rectal irrigation will be performed starting 48 hours after birth, twice daily for 5 consecutive days at 09:00 and 21:00. A 6 Fr feeding tube, 5 mL syringe, thermostatically controlled water bath (set at 37°C), sterile water-based lubricant, and sterile gloves will be used. The enema volume will be calculated as 5 mL/kg and warmed to 37°C. One end of the feeding tube will be connected to the syringe, and the other end will be gently inserted into the rectum after lubrication. The solution will be administered slowly over approximately 3 minutes, and the tube will then be carefully removed.

Rectal irrigation with maternal breast milk

Rectal irrigation will be performed starting 48 hours after birth, twice daily for 5 consecutive days at 09:00 and 21:00. A 6 Fr feeding tube, 5 mL syringe, thermostatically controlled water bath (set at 37°C), sterile water-based lubricant, and sterile gloves will be used. The enema volume will be calculated as 5 mL/kg and warmed to 37°C. One end of the feeding tube will be connected to the syringe, and the other end will be gently inserted into the rectum after lubrication. The solution will be administered slowly over approximately 3 minutes, and the tube will then be carefully removed. Normal saline will be used for rectal irrigation as an active comparator.

Rectal irrigation with normal saline

Eligibility Criteria

Age22 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm infants with a gestational age ≤32 weeks and birth weight ≤1500 g
  • Infants without meconium passage within the first 48 hours of life
  • Infants whose parents have provided written informed consent

You may not qualify if:

  • nfants with major congenital anomalies
  • Infants with gastrointestinal system anomalies
  • Infants in whom administration of maternal breast milk is contraindicated
  • Infants whose parents do not provide consent for participation
  • Infants who die within the first 72 hours of life

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Premature BirthEnterocolitis, Necrotizing

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesEnterocolitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessors analyzing microbiota data will be blinded to group allocation. Care providers and investigators will not be blinded due to the nature of the intervention.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a parallel design to one of two groups: rectal administration of maternal breast milk or rectal administration of normal saline. Outcomes will be compared between groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

March 17, 2026

First Posted

April 30, 2026

Study Start (Estimated)

June 15, 2026

Primary Completion (Estimated)

June 15, 2027

Study Completion (Estimated)

August 15, 2027

Last Updated

April 30, 2026

Record last verified: 2026-03